These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6159905)

  • 1. Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber.
    Langvad E; Hydén H; Petersen JK; Jordal R; Olsen G
    Arzneimittelforschung; 1980; 30(8):1245-6. PubMed ID: 6159905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma.
    Sibbitt WL; Bankhurst AD; Jumonville AJ; Saiki JH; Saiers JH; Doberneck RC
    Cancer Res; 1984 Feb; 44(2):852-6. PubMed ID: 6198076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH; D'Amore P; Rainey M
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.
    Golub SH; Dorey F; Hara D; Morton DL; Burk MW
    J Natl Cancer Inst; 1982 May; 68(5):703-10. PubMed ID: 6175787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon: therapy in patients with cutaneous malignant melanoma in adjuvant setting].
    Wcisło G; Szczylik C
    Pol Merkur Lekarski; 2003 Jul; 15(85):5-8. PubMed ID: 14593950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon therapy of tumors with extracorporeal perfusion].
    Hydén H; Langvad E; Jordal R; Pedersen JK
    Lakartidningen; 1980 Nov; 77(47):4380-2. PubMed ID: 6163049
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of adjuvant interferon in node-positive melanoma.
    Cormier JN; Xing Y; Ding M; Cantor SB; Salter KJ; Lee JE; Mansfield PF; Gershenwald JE; Ross MI
    J Clin Oncol; 2007 Jun; 25(17):2442-8. PubMed ID: 17557957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance and feasibility of adjuvant treatment of stage II malignant melanoma with high-dose interferon-alpha].
    Bédane C; Le Brun V; Boulinguez S; Berdah JF; Bouyssou ML; Delpuget N; Bernard P; Tubiana-Mathieu N; Bonnetblanc JM
    Ann Dermatol Venereol; 1999 Feb; 126(2):142-6. PubMed ID: 10352829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment of malignant melanoma: where are we?
    Ascierto PA; Scala S; Ottaiano A; Simeone E; de Michele I; Palmieri G; Castello G
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):45-52. PubMed ID: 15990330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH; Kelley S; Chiu H; Stebbing N
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interrelations of natural cellular cytotoxicity and interferon systems in immobilization stress].
    Sukhikh FT; Nosik NN; Parshina OV; Van'ko LV; Meerson FZ
    Biull Eksp Biol Med; 1984 Nov; 98(11):593-5. PubMed ID: 6210120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
    Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
    J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential predictive marker for response to interferon in malignant melanoma.
    Wild PJ; Meyer S; Landthaler M; Hofstaedter F; Bosserhoff AK
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):456-9. PubMed ID: 17537037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary observations of immunomodulatory activity of lymphoblastoid interferon-alpha administered every other day or weekly.
    Neefe JR; Sullivan JE; Silgals R
    J Biol Response Mod; 1983; 2(5):441-9. PubMed ID: 6644348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant interferon therapy in malignant melanoma].
    Mohr P
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.